Neoclone Biotechnology
NeoClone produces high-quality monoclonal antibody products for the biotechnology and research markets. In addition to generating monoclonals through the traditional fusion technology NeoClone holds exclusive license to the ABL-MYC retroviral transformation system, a technique that produces monoclonal antibodies -"NeoClone®"-brand or "NeoAb®" antibodies - in an accelerated time and with cost savings. This allows NeoClone to provide custom antibodies faster and more cost effective.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
11 to 50 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Neoclone Biotechnology
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Neoclone Biotechnology
2 distinct titles indexed · top 2 shown.
- 1antibody company
- 1production scientist
Sign up to unlock all 2 contacts at Neoclone Biotechnology
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Neoclone Biotechnology
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.